Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

New evidence suggests that the risk for fracture increases within months of low-dose prednisone, challenging the idea of a ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Dutch biotech Laigo Bio has launched with 11.5 million euros ($12.7 million) in seed financing to progress its SureTAC ...

Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors Matthew Baker appointed as CEOLaigo Bio’s ...

-- Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors -- Matthew Baker appointed as CEO -- Laigo Bio's SureTAC (TM) membrane protein degradation ...

Researchers in Beijing have generated a transcriptomic atlas comparing human fetal tooth germs from the upper and lower jaws ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering ...